Deadline EXTENDED: Abstract Submission for #BOPA2026

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN

 

Deadline for Abstract Submission for the 29th Annual BOPA Conference 2026 has been EXTENDED!
Don’t miss the chance to showcase your work.

 

Delegates are invited to present results of their clinical and technical work as a poster with some selected as an oral presentation. The author/s should submit via the BOPA website by midnight on Monday 29th June 2026.

 

Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

 

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal.

 

Prizes:

• 1st Prize Oral Plenary: £1500 (to attend an international conference or pay towards research funding including open access publishing fees).
• 2nd Prize Oral Plenary: £500.

• All Oral Plenary presenters: free registration for BOPA 2027.
• All “Highly Recommended” presenters: free BOPA membership for 2027.
• The three best poster winners: free BOPA membership for 2027.

 

Click here for Call for Abstracts printable PDF

Click here for Abstract Marking Scheme as printable PDF 

 

Click here to go to the Abstract Submission Page

 

Latest News

By BOPA on 15th June 2026

The BOPA Training and Development Grant – BOPA Conference 2026

BOPA are offering (in collaboration with Gilead) 16 funded places to the BOPA 2026 Conference in London from 2-4th Oct 20265. Information can be found here – The BOPA Training and Development Grant…

Read article
By BOPA Education & Training Subcommittee on 12th June 2026

BOPA Publication – Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative  The study explored factors influencing cancer pharmacists’ progression through…

Read article
By BOPA AI Cancer Advisory Group on 12th June 2026

BOPA AI CAG contribute to the National Commission into the Regulation of AI in Healthcare: research, engagement and call for evidence findings

Recently, the MHRA invited feedback from individuals and organisations on the regulation of AI in healthcare across the UK. The BOPA AI CAG responded to this call for evidence, and…

Read article
By BOPA on 11th June 2026

Call for BOPA Award nominations

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article